Listed by the USPTO as HOFFMAN, SUSAN COE
Tech Center 2100 • Art Units: 1655 1663 1699 2178
This examiner grants 54% of resolved cases
HOFFMAN, SUSAN COE is a USPTO patent examiner in Tech Center 2100 and art unit 1655. The record includes 1091 resolved cases, a 54.2% allowance rate, a 25.7% interview lift, and a median of 1081 days to allowance. The allowance result indicates a divided disposition across the resolved docket, while the interview measure provides a practical reason to consider direct discussion of claim scope and cited art.
The listed companies are Meiji Co., Ltd., Givaudan S.A., and Nestlé S.A. The associated firms are WENDEROTH, LIND & PONACK, L.L.P., CURATOLO SIDOTI & TRILLIS CO., LPA, and ALSTON & BIRD LLP. The timing figure supports early planning for responses and client communications.
| App # | Title | Status | Assignee |
|---|---|---|---|
| 18898626 | METHODS AND COMPOSITIONS FOR REDUCING BLOOD LIPIDS IN A MAMMAL USING NATURALLY OCCURING PLANTS AND SPICES | Non-Final OA | Individual inventor |
| 18896884 | METHODS AND COMPOSITIONS USING DICHROSTACHYS GLOMERATA TO REDUCE ANXIETY, FOOD CRAVINGS AND STRESS AND IMPROVE MOOD, PHYSICAL HEALTH, MENTAL HEALTH, ENERGY AND HAPPINESS IN A MAMMAL | Non-Final OA | Individual inventor |
| 18432624 | COMPOSITION AND DELIVERY METHOD FOR TREATMENT OF PHARYNGEAL TONSIL | Non-Final OA | Individual inventor |
| 18224218 | POLYSACCHARIDE COMPOSITION AND METHOD FOR HEALTH MAINTENANCE AND STRENGTHENING THE IMMUNE SYSTEM | Final Rejection | Individual inventor |
| 18161055 | KINGLAIT SPORT DRINKS' LINE DESCRIPTION & METHODS OF MANUFACTURING | Final Rejection | Individual inventor |
| 17291270 | Antihypertensive Composition | Final Rejection | Individual inventor |
| 17628491 | COMPOSITIONS AND METHODS TO AFFECT HUMAN GUT MICROBES | Final Rejection | Intercontinental Great Brands LLC |
| 18569614 | MONK FRUIT EXTRACT AND METHOD FOR PRODUCING SAME | Non-Final OA | DAICEL CORPORATION |
| 18697585 | COMPOSITION COMPRISING PRUNE FOR PREVENTING OR RELIEVING LOW ANTERIOR RESECTION SYNDROME | Final Rejection | SAMSUNG LIFE PUBLIC WELFARE FOUNDATION |
| 18396942 | METHOD FOR TREATING DERMATITIS AND PHARMACEUTICAL COMPOSITION FOR TREATING DERMATITIS CONTAINING AN ADENOSTEMMA LAVENIA EXTRACT | Final Rejection | Industrial Technology Research Institute |
| 18872093 | CACAO DERIVED COMPOSITION, AS WELL AS MOISTURIZING AGENT, SKIN QUALITY IMPROVING AGENT, HAIR QUALITY IMPROVING AGENT, COSMETIC FOR SKIN, COSMETIC FOR HAIR, PHARMACEUTICAL COMPOSITION AND FOOD COMPOSITION EACH CONTAINING THE CACAO DERIVED COMPOSITION | Non-Final OA | MEIJI CO., LTD. |
| 18872126 | CACAO DERIVED COMPOSITION, AS WELL AS MOISTURIZING AGENT, SKIN QUALITY IMPROVING AGENT, HAIR QUALITY IMPROVING AGENT, COSMETIC FOR SKIN, COSMETIC FOR HAIR, PHARMACEUTICAL COMPOSITION AND FOOD COMPOSITION EACH CONTAINING THE CACAO DERIVED COMPOSITION | Non-Final OA | MEIJI CO., LTD. |
| 18578588 | COMPOSITION FOR INDUCING AUTOPHAGY | Final Rejection | MEIJI CO., LTD. |
| 18757797 | SENOTHERAPY COMPOSITION CONTAINING CAMELLIA SINENSIS EXTRACT | Non-Final OA | AMOREPACIFIC CORPORATION |
| 18285786 | LIGUSTRUM LUCIDUM EXTRACT USEFUL FOR THE TREATMENT AND/OR CARE OF THE SKIN | Non-Final OA | Lubrizol Advanced Materials, Inc. |
| 18814986 | BED BUG CONTROL COMPOSITION | Non-Final OA | Pouch Pac Innovations, LLC |
| 18846820 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING ALZHEIMER’S DISEASE, COMPRISING, AS ACTIVE INGREDIENT, LACTIC ACID BACTERIA FERMENTATION SOLUTION OF MORI FRUCTUS EXTRACT | Non-Final OA | DONGGUK UNIVERSITY INDUSTRY-ACADEMY COOPERATION FOUNDATION |
| 18558183 | COMPOSITIONS | Final Rejection | Givaudan SA |
| 17619014 | EUTECTIC EXTRACTION OF SOLIDS | Final Rejection | Givaudan SA |
| 18845647 | COMPOSITION FOR PREVENTION OR TREATMENT OF NEUROINFLAMMATION, CONTAINING DAPHNE GENKWA FLOWER BUD EXTRACT AS ACTIVE INGREDIENT | Non-Final OA | CATHOLIC KWANDONG UNIVERSITY INDUSTRY FOUNDATION |
| 18257639 | AMANITA MUSCARIA COMPOUNDS | Non-Final OA | CAAMTECH, INC. |
| 18556992 | GEL FOR THE REGENERATION OF MUCOSAE | Final Rejection | POLITECNICO DI MILANO |
| 18830046 | Composition Containing Collagen | Final Rejection | YUJIAN International Biotechnology, Inc. |
| 18692974 | Anti-Oxidant Repair Ganoderma Lucidum Extract and Preparation Method Therefor | Non-Final OA | Guangdong Yuewei Edible Fungi Technology Co., Ltd. |
| 18837082 | COMPOSITION COMPRISING A MIXTURE OF DHA AND/OR EPA AND A PHOSPHOLIPID OF PLANT ORIGIN | Non-Final OA | POLARIS |
| 17602644 | THERAPEUTIC AGENT FOR FIBROSIS, INFLAMMATION, AND/OR AGING DISEASE | Non-Final OA | THE JIKEI UNIVERSITY |
| 18770143 | APPLICATION OF PURIFIED MUSHROOM BETA GLUCAN IN PREVENTING, IMPROVING OR TREATING ALZHEIMER'S DISEASE, DEMENTIA OR BRAIN FUNCTION DEGENERATION | Non-Final OA | Shiu-Nan CHEN |
| 18713294 | ANTI-AGEING SUPPLEMENT | Non-Final OA | DORMOUSE BV |
| 18116440 | PLANT EXTRACTS WITH ANTI-DIABETIC AND OTHER USEFUL ACTIVITIES | Final Rejection | Housey Pharmaceutical Research Laboratories, L.L.C. |
| 18709420 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING MUSCLE DISEASES | Final Rejection | KOSA BIO INC. |
IP Author analyzes examiner patterns and generates tailored response strategies with the highest chance of allowance.
Build Your Strategy54.2% of resolved applications examined by Susan Coe Hoffman were allowed (1,091 resolved cases), compared with 43.3% across Art Unit 1655 over the last five years.
This examiner's interview lift is +25.7 percentage points: the difference in allowance rate between resolved applications that had an examiner interview and those that did not.
Applications allowed by Susan Coe Hoffman took 1,081 days on average from filing to allowance.
Susan Coe Hoffman examines applications in Art Unit 1655 in Tech Center 2100 (Computing & Software).
